1.

Record Nr.

UNINA9910708149803321

Autore

Chesnes Matthew

Titolo

Banning Foreign Pharmacies from Sponsored Search : The Online Consumer Response / / Matthew Chesnes, Weijia (Daisy) Dai, Ginger Zhe Jin

Pubbl/distr/stampa

Cambridge, Mass, : National Bureau of Economic Research, 2014

Washington, DC : , : Bureau of Economics, Federal Trade Commission, , 2014

Descrizione fisica

1 online resource : illustrations (black and white);

Collana

NBER working paper series ; no. w20088

Classificazione

D83

I18

K32

L81

Altri autori (Persone)

DaiWeijia (

JinGinger Zhe

Soggetti

Search • Learning • Information and Knowledge • Communication • Belief • Unawareness

Government Policy • Regulation • Public Health

Energy, Environmental, Health, and Safety Law

Retail and Wholesale Trade • e-Commerce

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

May 2014.

Nota di bibliografia

Includes bibliographical references (pages 26-28).

Sommario/riassunto

Increased competition from the internet has raised concerns about the quality of prescription drugs sold online. Given the pressure from the Department of Justice, Google agreed to ban pharmacies not certified by the National Association of Boards of Pharmacy (NABP) from sponsored search listings. Using comScore click-through data originated from health-related queries, we study how the ban affects consumer search and click behavior in a difference-in-differences framework using the synthetic control method. We find that non-NABP-certified pharmacies receive fewer clicks after the ban and this effect is heterogeneous. In particular, pharmacies not certified by the NABP, but certified by other sources (other-certified websites), experience an



increase in organic clicks that partially offsets the loss in paid clicks after the ban. In contrast, pharmacies not certified by any certification agencies experience much lower rates of substitution in organic clicks. These results suggest that the ban has increased the search cost for other-certified websites, but at least some consumers overcome the search cost by switching from sponsored to organic links. The lower substitution for uncertified websites may be explained by the rising consumer concerns about the quality of drugs sold on uncertified websites after the ban.